Woodline Partners LP Day One Biopharmaceuticals, Inc. Transaction History
Woodline Partners LP
- $11 Billion
- Q3 2024
A detailed history of Woodline Partners LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 797,333 shares of DAWN stock, worth $9.61 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
797,333
Previous 707,531
12.69%
Holding current value
$9.61 Million
Previous $9.75 Million
13.92%
% of portfolio
0.1%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding DAWN
# of Institutions
180Shares Held
84MCall Options Held
148KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$94.9 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$77.5 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$70.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$58.7 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$54.6 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $885M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...